Publications by authors named "M Nieder"

Claim this Profile
L
Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide.
Jena Schmitz, Eric Gaskill, Samantha Price, Biwei Cao, Jongphil Kim, Michael Nieder

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia.
Eric Gaskill, Omar Albanyan, Syeda Mahrukh Hussnain Naqvi, Qianxing Mo, Athena Belfon, Michael Nieder

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant.
Hany Elmariah, Jongphil Kim, Rebecca Gonzalez, Elizabeth DiMaggio, Samer Sansil, Michael Nieder

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633).
E J Ladas, W Collier, H Park, J J Auletta, C C Dvorak, M Nieder

Transplant Cell Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
Adetola A Kassim, Mark C Walters, Mary Eapen, Madoc Smith, Brent R Logan, Michael Nieder

NEJM Evid· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis